Literature DB >> 21673342

DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes.

Oliver Nussbaumer1, Georg Gruenbacher, Hubert Gander, Martin Thurnher.   

Abstract

Bisphosphonates are mainly used for the inhibition of osteoclast-mediated bone resorption but also have been shown to induce γδ T-cell activation. Using IL-2-primed cultures of CD56(+) peripheral blood mononuclear cells, we show here that zoledronic acid (zoledronate) could induce IFN-γ production not only in γδ T lymphocytes but, surprisingly, also in natural killer (NK) cells in a manner that depended on antigen-presenting cells, which share properties of inflammatory monocytes and dendritic cells (DCs; here referred to as DC-like cells). In the presence of γδ T lymphocytes, DC-like cells were rapidly eliminated, and NK cell IFN-γ production was silenced. Conversely, in the absence of γδ T lymphocytes, DC-like cells were spared, allowing NK cell IFN-γ production to proceed. γδ T cell-independent NK cell activation in response to zoledronate was because of downstream depletion of endogenous prenyl pyrophosphates and subsequent caspase-1 activation in DC-like cells, which then provide mature IL-18 and IL-1β for the activation of IL-2-primed NK cells. Pharmacologic inhibition of caspase-1 almost abolished IFN-γ production in NK cells and γδ T lymphocytes, indicating that caspase-1-mediated cytokine maturation is the crucial mechanism underlying innate lymphocyte activation in response to zoledronate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21673342     DOI: 10.1182/blood-2011-01-328526

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

Review 1.  γδ-T cells: an unpolished sword in human anti-infection immunity.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2012-10-15       Impact factor: 11.530

2.  Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.

Authors:  Alanna S Murday; Suchita Chaudhry; C David Pauza
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

3.  Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case.

Authors:  S Deshayes; N Martin Silva; J Cogez; A Baldolli; S Fedrizzi; B Bienvenu; A Aouba
Journal:  Osteoporos Int       Date:  2016-03-15       Impact factor: 4.507

4.  Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism.

Authors:  Georg Gruenbacher; Oliver Nussbaumer; Hubert Gander; Bernhard Steiner; Nicolai Leonhartsberger; Martin Thurnher
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

5.  Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.

Authors:  Qunzhou Zhang; Weihua Yu; Sumin Lee; Qilin Xu; Ali Naji; Anh D Le
Journal:  J Bone Miner Res       Date:  2015-07-14       Impact factor: 6.741

6.  IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.

Authors:  Qunzhou Zhang; Ikiru Atsuta; Shiyu Liu; Chider Chen; Shihong Shi; Songtao Shi; Anh D Le
Journal:  Clin Cancer Res       Date:  2013-04-24       Impact factor: 12.531

7.  Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

Authors:  Emma Di Carlo; Paola Bocca; Laura Emionite; Michele Cilli; Giuseppe Cipollone; Fabio Morandi; Lizzia Raffaghello; Vito Pistoia; Ignazia Prigione
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

8.  Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.

Authors:  Tomoharu Sugie; Kaoru Murata-Hirai; Masashi Iwasaki; Craig T Morita; Wen Li; Haruki Okamura; Nagahiro Minato; Masakazu Toi; Yoshimasa Tanaka
Journal:  Cancer Immunol Immunother       Date:  2012-11-15       Impact factor: 6.968

9.  Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!

Authors:  Hamdy A Azim; Nermine S Kamal; Rafaat A Malak
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

10.  Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.

Authors:  Daniel W Fowler; John Copier; Angus G Dalgleish; Mark D Bodman-Smith
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.